DaVita Inks $55 Million Settlement In Epogen FCA Suit
Kidney care provider DaVita Inc. said Monday it had reached a $55 million settlement agreement in a qui tam False Claims Act suit alleging it fraudulently billed the federal government for...To view the full article, register now.
Already a subscriber? Click here to view full article